178 related articles for article (PubMed ID: 31335628)
41. Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.
Batchelor R; Gilmartin JF; Kemp W; Hopper I; Liew D
J Gastroenterol Hepatol; 2017 Aug; 32(8):1426-1435. PubMed ID: 28128476
[TBL] [Abstract][Full Text] [Related]
42. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
Brusselaers N; Engstrand L; Lagergren J
Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
[TBL] [Abstract][Full Text] [Related]
43. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Metaanalysis.
Chenchula S; Sharma P; Ghanta MK; Amerneni KC; Rajakarunakaran P; Saggurthi P; Chandra MB; Gupta R; Chavan M
Curr Diabetes Rev; 2024 Jan; ():. PubMed ID: 38243950
[TBL] [Abstract][Full Text] [Related]
44. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
[TBL] [Abstract][Full Text] [Related]
45. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding.
Komori K; Kubokawa M; Ihara E; Akahoshi K; Nakamura K; Motomura K; Masumoto A
World J Gastroenterol; 2017 Jan; 23(3):496-504. PubMed ID: 28210086
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the Use of Vonoprazan and Proton Pump Inhibitors for the Treatment of Peptic Ulcers Resulting from Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis.
He HS; Li BY; Chen QT; Song CY; Shi J; Shi B
Med Sci Monit; 2019 Feb; 25():1169-1176. PubMed ID: 30755541
[TBL] [Abstract][Full Text] [Related]
48. Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review.
Shiraev TP; Bullen A
Heart Lung Circ; 2018 Apr; 27(4):443-450. PubMed ID: 29233498
[TBL] [Abstract][Full Text] [Related]
49. Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study.
Lei WY; Wang JH; Yi CH; Liu TT; Hung JS; Wong MW; Bair MJ; Vaezi MF; Orr WC; Chen CL
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101397. PubMed ID: 32224118
[TBL] [Abstract][Full Text] [Related]
50. Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.
Farhat N; Fortin Y; Haddad N; Birkett N; Mattison DR; Momoli F; Wu Wen S; Krewski D
Crit Rev Toxicol; 2019 Mar; 49(3):215-261. PubMed ID: 31192763
[TBL] [Abstract][Full Text] [Related]
51. Prophylaxis for Stress Ulcers With Proton Pump Inhibitors Is Not Associated With Increased Risk of Bloodstream Infections in the Intensive Care Unit.
Cohen ME; Hathway JM; Salmasian H; Liu J; Terry M; Abrams JA; Freedberg DE
Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1030-1036.e1. PubMed ID: 28110095
[TBL] [Abstract][Full Text] [Related]
52. Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.
Sherwood MW; Melloni C; Jones WS; Washam JB; Hasselblad V; Dolor RJ
J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26514161
[TBL] [Abstract][Full Text] [Related]
53. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
54. Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials.
McQuaid KR; Laine L
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):553-63. PubMed ID: 15952097
[TBL] [Abstract][Full Text] [Related]
55. Perils and pitfalls of long-term effects of proton pump inhibitors.
Wilhelm SM; Rjater RG; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
[TBL] [Abstract][Full Text] [Related]
56. Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.
Sultan N; Nazareno J; Gregor J
Can J Gastroenterol; 2008 Sep; 22(9):761-6. PubMed ID: 18818790
[TBL] [Abstract][Full Text] [Related]
57. Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.
Tran-Duy A; Vanmolkot FH; Joore MA; Hoes AW; Stehouwer CD
Int J Clin Pract; 2015 Oct; 69(10):1088-111. PubMed ID: 25846476
[TBL] [Abstract][Full Text] [Related]
58. Proton Pump Inhibitors' Use and Risk of Iron Deficiency Anaemia: A Systematic Review and Meta-analysis.
Ali MD
Curr Rev Clin Exp Pharmacol; 2023; 18(2):158-166. PubMed ID: 35255801
[TBL] [Abstract][Full Text] [Related]
59. Evaluation and management of hypersensitivity to proton pump inhibitors.
Bose S; Guyer A; Long A; Banerji A
Ann Allergy Asthma Immunol; 2013 Dec; 111(6):452-7. PubMed ID: 24267357
[TBL] [Abstract][Full Text] [Related]
60. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
